Different effects of low-dose transdermal and oral oestrogen therapy on procarboxypeptidase U an inhibitor of fibrinolysis in healthy postmenopausal women a randomised placebo-controlled study

M.S. Post, J.R. Leurs, M.J. van der Mooren*, W.M. van Baal, D.F. Hendriks, C.D.A. Stehouwer, P. Kenemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)620-622
JournalThrombosis and Haemostasis
Publication statusPublished - 1 Jan 2005

Cite this